{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:33:35Z","timestamp":1778643215237,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["2\u20135"],"award-info":[{"award-number":["2\u20135"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20am0101080"],"award-info":[{"award-number":["JP20am0101080"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20am0101098"],"award-info":[{"award-number":["JP20am0101098"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009665","name":"Vehicle Racing Commemorative Foundation","doi-asserted-by":"publisher","award":["6303"],"award-info":[{"award-number":["6303"]}],"id":[{"id":"10.13039\/100009665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02805"],"award-info":[{"award-number":["22H02805"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06652"],"award-info":[{"award-number":["22K06652"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15244"],"award-info":[{"award-number":["22K15244"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.coph.2023.102356","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T20:18:45Z","timestamp":1677269925000},"page":"102356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Drug development for the treatment of RyR1-related skeletal muscle diseases"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-2980","authenticated-orcid":false,"given":"Takashi","family":"Murayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagomi","family":"Kurebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kagechika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2023.102356_bib1","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16434.1","article-title":"Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling","volume":"7","author":"Dulhunty","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.coph.2023.102356_bib2","first-page":"22","article-title":"The ryanodine receptor as a sensor for intracellular environments in muscles","author":"Kobayashi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2023.102356_bib3","first-page":"443","article-title":"Excitation-contraction coupling alterations in myopathies","volume":"3","author":"Marty","year":"2016","journal-title":"J\u00a0Neuromuscul Dis"},{"key":"10.1016\/j.coph.2023.102356_bib4","first-page":"154","article-title":"Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies","author":"Rossi","year":"2022","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.coph.2023.102356_sref5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1124\/mol.117.111468","article-title":"Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+-release channels","volume":"94","author":"Murayama","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2023.102356_sref6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1087057116674312","article-title":"High-throughput screens to discover small-molecule modulators of ryanodine receptor calcium release channels","volume":"22","author":"Rebbeck","year":"2017","journal-title":"SLAS Discov"},{"key":"10.1016\/j.coph.2023.102356_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/physrev.1991.71.3.849","article-title":"Voltage sensor of excitation-contraction coupling in skeletal muscle","volume":"71","author":"Rios","year":"1991","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2023.102356_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.ph.56.030194.002335","article-title":"Control of calcium release in functioning skeletal muscle fibers","volume":"56","author":"Schneider","year":"1994","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.coph.2023.102356_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbamcr.2018.12.004","article-title":"STAC proteins: the missing link in skeletal muscle EC coupling and new regulators of calcium channel function","volume":"1866","author":"Flucher","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.coph.2023.102356_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100874","article-title":"Structure and function of STAC proteins: calcium channel modulators and critical components of muscle excitation-contraction coupling","volume":"297","author":"Rufenach","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2023.102356_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12551-020-00610-x","article-title":"Excitation-contraction coupling in skeletal muscle: recent progress and unanswered questions","volume":"12","author":"Shishmarev","year":"2020","journal-title":"Biophys Rev"},{"key":"10.1016\/j.coph.2023.102356_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00040.2008","article-title":"Calcium-induced calcium release in skeletal muscle","volume":"89","author":"Endo","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2023.102356_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cell.2016.08.075","article-title":"Structural basis for gating and activation of RyR1","volume":"167","author":"des Georges","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coph.2023.102356_bib14","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1038\/s41467-022-30429-x","article-title":"Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations","volume":"13","author":"Kobayashi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2023.102356_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pbiomolbio.2010.10.003","article-title":"Two ryanodine receptor isoforms in nonmammalian vertebrate skeletal muscle: possible roles in excitation-contraction coupling and other processes","volume":"105","author":"Murayama","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.coph.2023.102356_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1085\/jgp.201711959","article-title":"Calcium-induced release of calcium in muscle: 50 years of work and the emerging consensus","volume":"150","author":"Rios","year":"2018","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.coph.2023.102356_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/emboj.2011.386","article-title":"Nitric oxide-induced calcium release via ryanodine receptors regulates neuronal function","volume":"31","author":"Kakizawa","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.coph.2023.102356_bib18","doi-asserted-by":"crossref","first-page":"ra68","DOI":"10.1126\/scisignal.aad9813","article-title":"An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities","volume":"9","author":"Lopez","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.coph.2023.102356_bib19","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1074\/jbc.274.9.5995","article-title":"Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes","volume":"274","author":"Sei","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2023.102356_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.coph.2023.102356_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.coph.2023.102356_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1152\/physrev.1996.76.2.537","article-title":"Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects","volume":"76","author":"Mickelson","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2023.102356_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0002-9343(98)00108-9","article-title":"Malignant hyperthermia and central core disease: disorders of Ca2+ release channels","volume":"104","author":"Loke","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.coph.2023.102356_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2023.102356_bib25","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1529\/biophysj.104.048447","article-title":"Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1","volume":"87","author":"Dirksen","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.coph.2023.102356_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1050-1738(02)00163-9","article-title":"Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca2+ release channels?","volume":"12","author":"Dirksen","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.coph.2023.102356_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.coph.2023.102356_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13395-020-00243-4","article-title":"Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature","volume":"10","author":"Lawal","year":"2020","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.coph.2023.102356_bib29","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2023.102356_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/humu.20696","article-title":"Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores","volume":"29","author":"Monnier","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.coph.2023.102356_bib31","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/brain\/awm096","article-title":"Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies","volume":"130","author":"Zhou","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.coph.2023.102356_bib32","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/humu.22326","article-title":"RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling","volume":"34","author":"Zhou","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.coph.2023.102356_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1389201022666210910102516","article-title":"Therapies for RYR1-related myopathies: where we stand and the perspectives","volume":"28","author":"Beaufils","year":"2022","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.coph.2023.102356_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermia","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coph.2023.102356_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1113\/jphysiol.1981.sp013591","article-title":"The effect of dantrolene on the enhancement and diminution of tension evoked by staircase and by tetanus in rat muscle","volume":"311","author":"Krarup","year":"1981","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.coph.2023.102356_bib36","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2023.102356_bib37","doi-asserted-by":"crossref","first-page":"13810","DOI":"10.1074\/jbc.M006104200","article-title":"Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity","volume":"276","author":"Zhao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2023.102356_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.coph.2023.102356_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene: a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.coph.2023.102356_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","article-title":"Dantrolene dose response in awake man: implications for management of malignant hyperthermia","volume":"59","author":"Flewellen","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coph.2023.102356_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/EJA.0b013e3283439545","article-title":"Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs","volume":"28","author":"Schutte","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.coph.2023.102356_bib42","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0711074105","article-title":"Remodeling of ryanodine receptor complex causes \"leaky\" channels: a molecular mechanism for decreased exercise capacity","volume":"105","author":"Bellinger","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2023.102356_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054208","article-title":"Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107","volume":"8","author":"Mei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2023.102356_bib44","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.str.2022.04.010","article-title":"A\u00a0drug and ATP binding site in type 1 ryanodine receptor","volume":"30","author":"Melville","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.coph.2023.102356_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2044-5040-2-9","article-title":"Leaky ryanodine receptors in beta-sarcoglycan deficient mice: a potential common defect in muscular dystrophy","volume":"2","author":"Andersson","year":"2012","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.coph.2023.102356_bib46","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddaa278","article-title":"Ryanodine receptor remodeling in cardiomyopathy and muscular dystrophy caused by lamin A\/C gene mutation","volume":"29","author":"Dridi","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2023.102356_bib47","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00401-020-02150-w","article-title":"Intracellular calcium leak as a therapeutic target for RYR1-related myopathies","volume":"139","author":"Kushnir","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coph.2023.102356_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17460441.2020.1791079","article-title":"Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade","volume":"16","author":"Obergrussberger","year":"2021","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.coph.2023.102356_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-7362-0_9","article-title":"Thallium flux assay for measuring the activity of monovalent cation channels and transporters","volume":"1684","author":"Weaver","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.coph.2023.102356_bib50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1440-1681.2001.03503.x","article-title":"The power of single channel recording and analysis: its application to ryanodine receptors in lipid bilayers","volume":"28","author":"Laver","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.coph.2023.102356_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00240306","article-title":"Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel","volume":"114","author":"Meissner","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.coph.2023.102356_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10974-020-09575-6","article-title":"Regulatory mechanisms of ryanodine receptor\/Ca2+ release channel revealed by recent advancements in structural studies","volume":"42","author":"Ogawa","year":"2021","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.coph.2023.102356_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jmb.2014.08.004","article-title":"Ryanodine receptors: allosteric ion channel giants","volume":"427","author":"Van Petegem","year":"2015","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.coph.2023.102356_bib54","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.ddmec.2010.09.009","article-title":"Fixing ryanodine receptor Ca leak - a novel therapeutic strategy for contractile failure in heart and skeletal muscle","volume":"7","author":"Andersson","year":"2010","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1016\/j.coph.2023.102356_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1089\/ars.2005.7.870","article-title":"Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels","volume":"7","author":"Aracena","year":"2005","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.coph.2023.102356_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cvr\/cvp273","article-title":"A\u00a0mechanism of ryanodine receptor modulation by FKBP12\/12.6, protein kinase A, and K201","volume":"85","author":"Blayney","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.coph.2023.102356_bib57","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1073\/pnas.0813010106","article-title":"FRET-based mapping of calmodulin bound to the RyR1 Ca2+ release channel","volume":"106","author":"Cornea","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2023.102356_bib58","doi-asserted-by":"crossref","first-page":"19219","DOI":"10.1074\/jbc.M109.066944","article-title":"Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer","volume":"285","author":"Cornea","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2023.102356_bib59","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1016\/S0021-9258(19)50114-4","article-title":"FK506 binding protein associated with the calcium release channel (ryanodine receptor)","volume":"267","author":"Jayaraman","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2023.102356_bib60","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.bcp.2004.02.018","article-title":"Selenium compounds modulate the calcium release channel\/ryanodine receptor of rabbit skeletal muscle by oxidizing functional thiols","volume":"67","author":"Xia","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2023.102356_bib61","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41598-020-58461-1","article-title":"RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca2+ assays","volume":"10","author":"Rebbeck","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2023.102356_bib62","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.1800490115","article-title":"Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation","volume":"115","author":"Cully","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2023.102356_bib63","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1002\/cpph.71","article-title":"Assays for modulators of ryanodine receptor (RyR)\/Ca2+ release channel activity for drug discovery for skeletal muscle and heart diseases","volume":"87","author":"Murayama","year":"2019","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.coph.2023.102356_bib64","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/humu.23072","article-title":"Genotype-phenotype correlations of malignant hyperthermia and central core disease mutations in the central region of the RYR1 channel","volume":"37","author":"Murayama","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.coph.2023.102356_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130606","article-title":"Divergent activity profiles of type 1 ryanodine receptor channels carrying malignant hyperthermia and central core disease mutations in the amino-terminal region","volume":"10","author":"Murayama","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2023.102356_bib66","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/ncomms5153","article-title":"Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA","volume":"5","author":"Suzuki","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2023.102356_bib67","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejmech.2019.06.076","article-title":"Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay","volume":"179","author":"Mori","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.coph.2023.102356_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117027","article-title":"Development of a water-soluble ryanodine receptor 1 inhibitor","volume":"74","author":"Ishida","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.coph.2023.102356_sref69","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1038\/s41467-021-24644-1","article-title":"A\u00a0novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke","volume":"12","author":"Yamazawa","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2023.102356_bib70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.05-4497fje","article-title":"Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse","volume":"20","author":"Chelu","year":"2006","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102356_bib71","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bja.2018.07.008","article-title":"Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1","volume":"121","author":"Lopez","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.coph.2023.102356_bib72","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","article-title":"Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse","volume":"105","author":"Yang","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coph.2023.102356_bib73","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1096\/fj.11-197582","article-title":"Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage","volume":"26","author":"Yuen","year":"2012","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2023.102356_sref74","doi-asserted-by":"crossref","first-page":"13822","DOI":"10.1073\/pnas.1716461115","article-title":"De novo reconstitution reveals the proteins required for skeletal muscle voltage-induced Ca2+ release","volume":"114","author":"Perni","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2023.102356_sref75","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202213230","article-title":"A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery","volume":"154","author":"Murayama","year":"2022","journal-title":"J Gen Physiol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:57:19Z","timestamp":1761461839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489223000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":75,"alternative-id":["S1471489223000097"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2023.102356","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug development for the treatment of RyR1-related skeletal muscle diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2023.102356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102356"}}